Regeneron co-founders slow down compensation in 2021, netting just $13M combined after $270M in 2020
After Regeneron’s co-founders cleared 2020 with a potential $260 million in stock awards that could be cashed out in a few years, the total salary for the pair of billionaires has come down from its sky high perch.
CEO Len Schleifer and CSO George Yancopoulos, the pair at the forefront of the 34-year-old pharma, each earned approximately $6.4 million in 2021, putting them on the low side of CEO and top exec payouts in their industry. And for American pharmas, it puts the pair even lower on the pay totem pole compared to substantially larger pharma companies like J&J. Alex Gorsky, the former CEO and now executive chairman, brought in more than $26 million in pay and perks for 2021.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.